Meng‐Han Wu

578 total citations
13 papers, 386 citations indexed

About

Meng‐Han Wu is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Meng‐Han Wu has authored 13 papers receiving a total of 386 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Cancer Research and 4 papers in Oncology. Recurrent topics in Meng‐Han Wu's work include RNA modifications and cancer (7 papers), Cancer-related molecular mechanisms research (6 papers) and RNA Research and Splicing (4 papers). Meng‐Han Wu is often cited by papers focused on RNA modifications and cancer (7 papers), Cancer-related molecular mechanisms research (6 papers) and RNA Research and Splicing (4 papers). Meng‐Han Wu collaborates with scholars based in Taiwan and United States. Meng‐Han Wu's co-authors include Kwang‐Huei Lin, Chau‐Ting Yeh, Yang-Hsiang Lin, Ya‐Hui Huang, Hsiang‐Cheng Chi, I‐Hsiao Chung, Chung‐Ying Tsai, Mei‐Ling Cheng, Chia‐Jung Liao and Cheng-Yi Chen and has published in prestigious journals such as Nature Communications, Hepatology and Cancer Research.

In The Last Decade

Meng‐Han Wu

12 papers receiving 381 citations

Peers

Meng‐Han Wu
Meng‐Han Wu
Citations per year, relative to Meng‐Han Wu Meng‐Han Wu (= 1×) peers Jingsheng Yuan

Countries citing papers authored by Meng‐Han Wu

Since Specialization
Citations

This map shows the geographic impact of Meng‐Han Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meng‐Han Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meng‐Han Wu more than expected).

Fields of papers citing papers by Meng‐Han Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meng‐Han Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meng‐Han Wu. The network helps show where Meng‐Han Wu may publish in the future.

Co-authorship network of co-authors of Meng‐Han Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Meng‐Han Wu. A scholar is included among the top collaborators of Meng‐Han Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meng‐Han Wu. Meng‐Han Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Wu, Meng‐Han, Felipe Valença-Pereira, Francesca Cendali, et al.. (2024). Deleting the mitochondrial respiration negative regulator MCJ enhances the efficacy of CD8+ T cell adoptive therapies in pre-clinical studies. Nature Communications. 15(1). 4444–4444. 8 indexed citations
2.
Lin, Yang-Hsiang, et al.. (2024). ANGPTL3 overcomes sorafenib resistance via suppression of SNAI1 and CPT1A in liver cancer. Translational Oncology. 52. 102250–102250. 3 indexed citations
3.
Wu, Meng‐Han, Emily Giddings, Felipe Valença-Pereira, et al.. (2024). Abstract 4013: Increasing mitochondrial respiration by silencing MCJ/DnaJC15 enhances CD8 CAR-T cell therapy efficacy. Cancer Research. 84(6_Supplement). 4013–4013.
4.
Lin, Yang-Hsiang, Yu‐Chin Liu, Hsiang‐Cheng Chi, et al.. (2022). LPAL2 Suppresses Tumor Growth and Metastasis of Hepatocellular Carcinoma by Modulating MMP9 Expression. Cells. 11(16). 2610–2610. 9 indexed citations
5.
Lin, Yang-Hsiang, Meng‐Han Wu, Yi‐Chung Liu, et al.. (2021). LINC01348 suppresses hepatocellular carcinoma metastasis through inhibition of SF3B3-mediated EZH2 pre-mRNA splicing. Oncogene. 40(28). 4675–4685. 26 indexed citations
6.
Kleczko, Emily K., Jennifer Laskowski, Meng‐Han Wu, et al.. (2021). P53.05 Inhibition of Tumor Cell Intrinsic Complement Regulatory Proteins Leads to Decreased Tumor Growth in a Mouse Model of NSCLC. Journal of Thoracic Oncology. 16(10). S1127–S1128. 1 indexed citations
7.
Neuwelt, Alexander, Abigail K. Kimball, Amber M. Johnson, et al.. (2020). Cancer cell-intrinsic expression of MHC II in lung cancer cell lines is actively restricted by MEK/ERK signaling and epigenetic mechanisms. Journal for ImmunoTherapy of Cancer. 8(1). e000441–e000441. 37 indexed citations
8.
Lin, Yang-Hsiang, Meng‐Han Wu, Ya‐Hui Huang, Chau‐Ting Yeh, & Kwang‐Huei Lin. (2020). TUG1 Is a Regulator of AFP and Serves as Prognostic Marker in Non-Hepatitis B Non-Hepatitis C Hepatocellular Carcinoma. Cells. 9(2). 262–262. 18 indexed citations
9.
Lin, Yang-Hsiang, Meng‐Han Wu, Ya‐Hui Huang, et al.. (2018). Thyroid hormone negatively regulates tumorigenesis through suppression of BC200. Endocrine Related Cancer. 25(12). 967–979. 20 indexed citations
10.
Lin, Yang-Hsiang, Meng‐Han Wu, Chau‐Ting Yeh, & Kwang‐Huei Lin. (2018). Long Non-Coding RNAs as Mediators of Tumor Microenvironment and Liver Cancer Cell Communication. International Journal of Molecular Sciences. 19(12). 3742–3742. 56 indexed citations
11.
Wu, Meng‐Han, Ya‐Hui Huang, Chau‐Ting Yeh, et al.. (2017). Taurine up‐regulated gene 1 functions as a master regulator to coordinate glycolysis and metastasis in hepatocellular carcinoma. Hepatology. 67(1). 188–203. 127 indexed citations
12.
Lin, Yang-Hsiang, Meng‐Han Wu, Chia‐Jung Liao, et al.. (2015). Repression of microRNA-130b by thyroid hormone enhances cell motility. Journal of Hepatology. 62(6). 1328–1340. 47 indexed citations
13.
Chung, I‐Hsiao, Cheng-Yi Chen, Yang-Hsiang Lin, et al.. (2015). Thyroid hormone-mediated regulation of lipocalin 2 through the Met/FAK pathway in liver cancer. Oncotarget. 6(17). 15050–15064. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026